Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 20
1
Please wait...

About This Project

A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

Blast off!

Browse Other Projects on Experiment

Related Projects

Conservation Efforts to Protect Endangered Turtles of Sulawesi

Sulawesi, Indonesia, is home to many species found nowhere else on Earth. Although rich in biodiversity...

Probiotics for plants? Fighting insects by boosting corn immune systems

Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

Backer Badge Funded